AEON Biopharma
AEON
AEON
81 hedge funds and large institutions have $222M invested in AEON Biopharma in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+8
Holders Change %
+10.96%
% of All Funds
1.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
18
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BNP Paribas Financial Markets
Paris,
France
|
+$3.43M |
2 |
Janus Henderson Group
London,
United Kingdom
|
+$2.57M |
3 |
Calamos Advisors
Naperville,
Illinois
|
+$2.46M |
4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$1.81M |
5 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$956K |
Top Sellers
1 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$3.43M |
2 |
TCM
Tegean Capital Management
New York
|
-$491K |
3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$470K |
4 |
OCAM
Owl Creek Asset Management
New York
|
-$245K |
5 |
Citigroup
New York
|
-$245K |